August 2, 2024 01:28 PM EDT
R&D

Iron chela­tor ther­a­py un­ex­pect­ed­ly wors­ened Alzheimer’s dis­ease in clin­i­cal study

Ryan Cross

Senior Science Correspondent

PHILADEL­PHIA — Among the many mys­ter­ies of Alzheimer’s dis­ease is the role that iron plays. The met­al is vi­tal for trans­port­ing oxy­gen in the blood and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

When gen­er­a­tive AI meets the FDA: First dig­i­tal health ad­comm kicks off dis­cus­sion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times